Cipla gets four USFDA observations for three Goa facilities; stocks fall over 3%
Drug firm Cipla on Friday said the US health regulator has issued four observations across its three manufacturing facilities in Goa after the inspection.
Sep 30, 2016, 14:30 PM IST
Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets
The company stock closed at Rs 634.90, down 0.95 per cent, on the BSE.
Jun 03, 2015, 17:06 PM IST